Abstract
Introduction
While most patients with alcohol withdrawal (AW) respond to standard treatment that includes doses of benzo-diazepines, nutrition and good supportive care (non resistant alcohol withdrawal-NRAW), a subgroup may resist therapy (resistant alcohol withdrawal-RAW). This study describes a distinct group of AW patients, their sedative requirements, and hospital courses.
Methods
Over a period of 6 months, AW patients requiring 50 mg diazepam IV in the first hour were followed. We recorded admission indices and diazepam doses with vital signs at 1, 2, 3, 6, 12, and 24 hours. Patients were considered to have RAW if they required additional sedatives for control of symptoms and/or were having persistent abnormal vital signs despite the physicians’ choices of therapy.
Results
Nineteen patients were enrolled; all had similar admission indices. While the 4 NRAW had normal vital signs within 3 hours, all 15 RAW patients had abnormal vital signs; 15 RAW patients required escalating diazepam doses — 14 required barbiturates, 7 were intubated, and 5 had hypotension. Comparing groups: interval and total diazepam doses were not different at 1, 2, and 3 hours; interval doses at 6 and 12 hours, and total doses at 6, 12, and 24 hours were significantly different.
Conclusions
RAW patients require large doses of benzodiazepine administration, additional sedatives, and undergo complicated hospitalizations.
Keywords: alcohol, withdrawal, delirium, resistance
Full Text
The Full Text of this article is available as a PDF (135.2 KB).
Footnotes
There was no outside funding of any kind used for this study.
References
- 1.Saitz R, Mayo-Smith MF, Roberts MS, Redmond, et al. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. JAMA. 1994;272(7):519–523. doi: 10.1001/jama.272.7.519. [DOI] [PubMed] [Google Scholar]
- 2.Aaronson LM, Hinman DJ, Okamoto M. Effects of diazepam of ethanol withdrawal. J Pharmacol Exp Ther. 1982;221(2):319–25. [PubMed] [Google Scholar]
- 3.Wasilewski D, Matsumoto H, Kur E, Dziklinska A, Wozny E, Stencka K, Skalski M, Chaba P, Szelenberger Assessment of diazepam loading dose therapy of delirium tremens. Alcohol Alcohol. 1996;31(3):273–8. doi: 10.1093/oxfordjournals.alcalc.a008147. [DOI] [PubMed] [Google Scholar]
- 4.McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000;28(6):1781–4. doi: 10.1097/00003246-200006000-00014. [DOI] [PubMed] [Google Scholar]
- 5.Vinson DC, Menezes M. Admission alcohol level: a predictor of the course of alcohol withdrawal. J Fam Pract. 1991;33(2):161–7. [PubMed] [Google Scholar]
- 6.Manikant S, Tripathi BM, Chavan BS. Loading dose diazepam therapy for alcohol withdrawal state. Indian J Med Res. 1993;98:170–3. [PubMed] [Google Scholar]
- 7.Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc. 2001;76(7):695–701. doi: 10.4065/76.7.695. [DOI] [PubMed] [Google Scholar]
- 8.Isbell H, Fraser HF, Wikler A, Belleville RE, Eisenman AJ. An experimental study of the etiology of “rum fits” and delirium tremens. QJ Studies Alcohol. 1955;16(1):1–33. [PubMed] [Google Scholar]
- 9.Follesa P, Biggio F, Mancuso L, Cabras S, Caria S, Gorini G, Manca A, Orru A, Biggio G. Ethanol withdrawal-induced up-regulation of the alpha2 subunit of the GABAA receptor and its prevention by diazepam or gamma-hydroxybutyric acid. Brain Res Mol Brain Res. 2004;120(2):130–7. doi: 10.1016/j.molbrainres.2003.10.011. [DOI] [PubMed] [Google Scholar]
- 10.Goldstein DB, Kakihana R. Alcohol withdrawal reactions in mouse strains selectively bred for long or short sleep times. Life Sci. 1975;17(6):981–5. doi: 10.1016/0024-3205(75)90452-X. [DOI] [PubMed] [Google Scholar]